Company record · updated October 7, 2026
Glycomimetics Inc: 6 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs October 31, 2024 to April 30, 2025.
6observations
6source filings
6verified rows
2025-04-30most recent as-of date
Source rails for this company: N-PORT fund mark (6).
Reported by 3 filers: Fidelity Advisor Biotechnology Fund, Fidelity Small Cap Growth Fund, Fidelity Small Cap Growth K6 Fund.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2025-04-30 | price per share | 0.2253 USD | Fidelity Small Cap Growth Fund | VERIFIED | valUSD 2725985.8 / balance 12099897.0 [unspecified] | 000175272425160131 |
| 2025-04-30 | price per share | 0.2253 USD | Fidelity Small Cap Growth K6 Fund | VERIFIED | valUSD 908661.93 / balance 4033299.0 [unspecified] | 000175272425160147 |
| 2025-04-30 | price per share | 0.2253 USD | Fidelity Advisor Biotechnology Fund | VERIFIED | valUSD 6034732.39 / balance 26786508.0 [unspecified] | 000175272425159810 |
| 2024-10-31 | price per share | 0.2937 USD | Fidelity Small Cap Growth K6 Fund | VERIFIED | valUSD 1184741.25 / balance 4033299.0 [unspecified] | 000175272424297793 |
| 2024-10-31 | price per share | 0.2937 USD | Fidelity Small Cap Growth Fund | VERIFIED | valUSD 3554223.74 / balance 12099897.0 [unspecified] | 000175272424297811 |
| 2024-10-31 | price per share | 0.2937 USD | Fidelity Advisor Biotechnology Fund | VERIFIED | valUSD 7868268.86 / balance 26786508.0 [unspecified] | 000175272424297857 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price.